PEREGRINE CAPITAL MANAGEMENT LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 89 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2021$4,470,000
-33.6%
184,253
-12.2%
0.08%
-35.2%
Q4 2020$6,728,000
+16.2%
209,911
+9.6%
0.13%
-16.3%
Q3 2020$5,789,000191,5000.15%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$104,289,0004.42%
Boxer Capital, LLC 2,014,858$60,909,0002.10%
RA Capital Management 2,589,904$78,293,0001.43%
Artal Group S.A. 1,521,517$45,995,0001.12%
Ikarian Capital, LLC 358,941$10,851,0000.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$24,260,0000.59%
Bellevue Group AG 1,403,000$42,413,0000.59%
Logos Global Management LP 123,465$3,732,0000.48%
Casdin Capital, LLC 289,395$8,748,0000.39%
HighVista Strategies LLC 16,391$496,0000.36%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders